SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001267602-20-000109
Filing Date
2020-08-04
Accepted
2020-08-04 16:29:52
Documents
71
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q alim-20200630x10q.htm   iXBRL 10-Q 3573678
2 EX-31.1 alim-20200630xex31_1.htm EX-31.1 20893
3 EX-31.2 alim-20200630xex31_2.htm EX-31.2 21110
4 EX-32.1 alim-20200630xex32_1.htm EX-32.1 15895
  Complete submission text file 0001267602-20-000109.txt   11893169

Data Files

Seq Description Document Type Size
5 EX-101.SCH alim-20200630.xsd EX-101.SCH 44231
6 EX-101.CAL alim-20200630_cal.xml EX-101.CAL 62523
7 EX-101.DEF alim-20200630_def.xml EX-101.DEF 173923
8 EX-101.LAB alim-20200630_lab.xml EX-101.LAB 464025
9 EX-101.PRE alim-20200630_pre.xml EX-101.PRE 351391
10 EXTRACTED XBRL INSTANCE DOCUMENT alim-20200630x10q_htm.xml XML 2837921
Mailing Address 6120 WINDWARD PARKWAY STE 290 ALPHARETTA GA 30005
Business Address 6120 WINDWARD PARKWAY STE 290 ALPHARETTA GA 30005 678-990-5740
ALIMERA SCIENCES INC (Filer) CIK: 0001267602 (see all company filings)

IRS No.: 200028718 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34703 | Film No.: 201073726
SIC: 2834 Pharmaceutical Preparations